Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Quantum Biopharma ( (TSE:QNTM) ) has issued an update.
On December 22, 2025, Quantum BioPharma Ltd. announced that it had entered into an at-the-market offering agreement with Rodman & Renshaw LLC, allowing the company, at its discretion, to sell up to US$17.24 million of its Class B Subordinate Voting Shares directly into the U.S. market through Nasdaq at prevailing prices. The shares, which will not be sold on the Canadian Securities Exchange, will be issued under an effective U.S. shelf registration, with Rodman earning a commission of up to 3% on gross proceeds, and Quantum indicating that any funds raised will be directed to general corporate purposes and working capital, providing the company with flexible access to capital as it advances its drug development programs and maintains its investment portfolio.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a Toronto-based biopharmaceutical company focused on developing innovative assets and biotech solutions targeting challenging neurodegenerative and metabolic disorders, as well as alcohol misuse disorders, with drug candidates at various stages of development. Through its wholly owned subsidiary Lucid Psycheceuticals, it is advancing Lucid-MS, a patented new chemical entity that has shown preclinical potential to prevent and reverse myelin degradation associated with multiple sclerosis. The company has also licensed its UNBUZZD formulation for rapid relief from the effects of alcohol consumption to Celly Nutrition Corp. for use in the consumer recreational sector, while continuing to develop alcohol misuse treatments for the healthcare market, and it holds a portfolio of property-secured loans through FSD Strategic Investments Inc.
YTD Price Performance: 110.60%
Average Trading Volume: 4,739
Technical Sentiment Signal: Sell
Current Market Cap: C$47.03M
Learn more about QNTM stock on TipRanks’ Stock Analysis page.